DOI:
10.1055/s-00000031
Klinische Monatsblätter für Augenheilkunde
LinksClose Window
References
Schmidt EK, Mustonen T, Kiuru-Enari S. et al.
Finnish gelsolin amyloidosis causes significant disease burden but does not affect survival: FIN-GAR phase II study.
Orphanet J Rare Dis 2020;
15: 19
doi:10.1186/s13023-020-1300-5
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.